Literature DB >> 8586627

Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats.

T Ishii1, M Sato, K Sudo, M Suzuki, H Nakai, T Hishida, T Niwa, K Umezu, S Yuasa.   

Abstract

The effects of recombinant human hepatocyte growth factor (HGF) on liver growth and function of normal and partially hepatectomized rats have been examined. HGF was continuously administered into the jugular vein because it was rapidly eliminated from the plasma (t1/2 alpha; approximately 4.5 min) and degraded. In normal rats, the labeling index of hepatocytes was increased about 6 times by the administration of HGF. HGF also decreased the prothrombin time and increased the hepaplastin and serum albumin content. In 70%-hepatectomized rats, HGF stimulated liver regeneration and increased the level of blood proteins such as hepaplastin in a dose-dependent manner. The stimulation of serum protein level seemed to result from not only the increase of hepatic cell number but also the direct effect of HGF on the protein production in hepatocytes, because HGF rapidly enhanced the protein synthesis prior to the increase of cell number and increased the mRNA content of albumin in the liver in vivo. In addition, a combination of heparin with HGF further accelerated the effects of HGF described above, possibly due to the decrease of HGF clearance. These findings suggest that HGF accelerates both the hepatic regeneration and function in vivo, and that rhHGF is clinically expected to be a potent therapeutic agent in hepatectomy and liver injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586627     DOI: 10.1093/oxfordjournals.jbchem.a124814

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

1.  Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure.

Authors:  Chuanlong Zhu; Yuwen Li; Wenting Li; Quan Wu; Rentao Gao
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

2.  Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Hiroki Tojima; Satoru Kakizaki; Takashi Kosone; Norio Horiguchi; Yuichi Yamazaki; Ken Sato; Hitoshi Takagi; Masatomo Mori
Journal:  Hepatol Int       Date:  2011-08-05       Impact factor: 6.047

3.  Mathematical model of liver regeneration in human live donors.

Authors:  V Periwal; J R Gaillard; L Needleman; C Doria
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

4.  Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes.

Authors:  Mihye Kim; Ji Youn Lee; Caroline N Jones; Alexander Revzin; Giyoong Tae
Journal:  Biomaterials       Date:  2010-02-11       Impact factor: 12.479

Review 5.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Authors:  Keisaku Sato; Marco Marzioni; Fanyin Meng; Heather Francis; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

6.  Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

Authors:  M Tahara; K Matsumoto; T Nukiwa; T Nakamura
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112).

Authors:  Sotaro Motoi; Mai Uesugi; Takashi Obara; Katsuhiro Moriya; Yoshihisa Arita; Hideaki Ogasawara; Motohiro Soejima; Toshio Imai; Tetsu Kawano
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

8.  Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice.

Authors:  Sivasami Pulavendran; Chellan Rose; Asit Baran Mandal
Journal:  J Nanobiotechnology       Date:  2011-04-28       Impact factor: 10.435

9.  Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Authors:  Akio Ido; Akihiro Moriuchi; Masatsugu Numata; Toshinori Murayama; Satoshi Teramukai; Hiroyuki Marusawa; Naohisa Yamaji; Hitoshi Setoyama; Il-Deok Kim; Tsutomu Chiba; Shuji Higuchi; Masayuki Yokode; Masanori Fukushima; Akira Shimizu; Hirohito Tsubouchi
Journal:  J Transl Med       Date:  2011-05-08       Impact factor: 5.531

10.  Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy.

Authors:  Kari Nejak-Bowen; Anne Orr; William C Bowen; George K Michalopoulos
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.